Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-12-032076)

Filing Details

Accession Number:: 0001104659-12-032076
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-05-02 17:06:27
Reporting Period:: 2012-04-30

Filing Date:: 2012-05-02
Accepted Time:: 2012-05-02 17:06:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
880771	Sciclone Pharmaceuticals Inc	SCLN	Pharmaceutical Preparations (2834)	943116852

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1092601	Spa Finanziaria Tau Sigma	Via Sudafrica 20 00144 Rome Italy		No	No	Yes	No
1168857	Lda Farmaceutica Defiante	Rua Dos Ferreiros,260 Funchal Madeira S1 9000-082		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-04-30	6,328,469	$5.25	252,469	No	4	S	Indirect	I
Common Stock	Disposition	2012-04-30	252,469	$5.25	0	No	4	D	Indirect	I

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	I
No	4	D	Indirect	I

Footnotes

Prior to their disposition, these shares were directly owned by Defiante Farmaceutica S.A. ("Defiante"). Defiante is 58% directly owned by Sigma-Tau Finanziaria S.p.A. ("Sigma-Tau") and 42% directly owned by Sigma-Tau's wholly-owned subsidiary Sigma-Tau International S.A.